NASDAQ:GERN | Insider Transactions — Page 2 | GERON CORP

GERN Insider Transactions — Page 2

125 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 101–125; provenance stays internal.

Insider profileRoleDateTransactionSharesPrice
HARLEY CALVINVP and CSO2009-01-29Sale5,489.0$7.14
OKARMA THOMASPresident and CEO2009-01-05Sale12,512.0$4.9
LEBKOWSKI JANESVP Regen Medicine2009-01-05Sale8,861.0$4.9
BEHRS MELISSA KELLYSVP Oncology2009-01-05Sale8,861.0$4.9
HARLEY CALVINVP and CSO2009-01-05Sale8,861.0$4.9
GREENWOOD DAVIDEVP and CFO2009-01-05Sale10,732.0$4.9
EARP DAVIDSVP Bus Dev, Chief Patnt Couns2009-01-05Sale8,861.0$4.9
BEHRS MELISSA KELLYSVP Oncology2008-11-05Sale23,845.0$4.05
OKARMA THOMASPresident and CEO2008-01-04Sale13,166.0$5.34
LEBKOWSKI JANESVP Regen Medicine2008-01-04Sale8,911.0$5.34
BEHRS MELISSA KELLYSVP Oncology2008-01-04Sale8,911.0$5.34
HARLEY CALVINVP and CSO2008-01-04Sale8,911.0$5.34
GREENWOOD DAVIDEVP and CFO2008-01-04Sale11,039.0$5.34
EARP DAVIDSVP Bus Dev, Chief Patnt Couns2008-01-04Sale8,911.0$5.34
GREENWOOD DAVIDEVP and CFO2007-11-12Sale4,000.0$7.2
HARLEY CALVINVP and CSO2007-05-18Sale3,000.0$9.13
HARLEY CALVINVP and CSO2007-05-18Sale9,000.0$9.15
HARLEY CALVINVP and CSO2007-05-18Sale9,000.0$9.21
HARLEY CALVINVP and CSO2007-05-18Sale9,000.0$9.22
BEHRS MELISSA KELLYVP, Oncology2006-01-09Sale8,441.0$8.56
LEBKOWSKI JANESVP, Regenerative Medicine2006-01-09Sale10,676.0$8.56
OKARMA THOMASPresident and CEO2006-01-09Sale12,320.0$8.56
HARLEY CALVINChief Scientific Officer2006-01-09Sale9,183.0$8.56
GREENWOOD DAVIDExecutive VP and CFO2006-01-09Sale12,183.0$8.56
EARP DAVIDSVP Bus Dev / Chf Patent Couns2006-01-09Sale11,323.0$8.56